Boston Common Asset Management LLC Has $27.50 Million Stock Holdings in Colgate-Palmolive Company $CL

Key Points

• Boston Common Asset Management LLC increased its stake in Colgate-Palmolive Company by 2.2%, holding 302,551 shares valued at approximately $27.5 million.
• Colgate-Palmolive reported earnings per share of $0.92 for the last quarter, exceeding the estimated $0.89, and generated revenue of $5.11 billion.
• The company announced a quarterly dividend of $0.52 per share, yielding 2.7%, with the payment date set for November 14th.

Boston Common Asset Management LLC lifted its holdings in Colgate-Palmolive Company (NYSE:CL - Free Report) by 2.2% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 302,551 shares of the company's stock after buying an additional 6,572 shares during the period. Boston Common Asset Management LLC's holdings in Colgate-Palmolive were worth $27,502,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Personal CFO Solutions LLC purchased a new stake in shares of Colgate-Palmolive during the first quarter worth $285,000. Vision Capital Management Inc. purchased a new stake in shares of Colgate-Palmolive during the first quarter worth $322,000. Autumn Glory Partners LLC raised its holdings in shares of Colgate-Palmolive by 67.4% during the first quarter. Autumn Glory Partners LLC now owns 8,905 shares of the company's stock worth $851,000 after acquiring an additional 3,586 shares in the last quarter. Financial Gravity Asset Management Inc. purchased a new stake in shares of Colgate-Palmolive during the first quarter worth $2,166,000. Finally, Penserra Capital Management LLC raised its holdings in shares of Colgate-Palmolive by 398.6% during the first quarter. Penserra Capital Management LLC now owns 10,651 shares of the company's stock worth $997,000 after acquiring an additional 8,515 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company's stock.

Colgate-Palmolive Price Performance

Shares of NYSE:CL opened at $78.01 on Friday. The business has a 50 day moving average price of $83.29 and a 200 day moving average price of $88.32. Colgate-Palmolive Company has a twelve month low of $77.91 and a twelve month high of $102.61. The company has a market cap of $63.05 billion, a price-to-earnings ratio of 21.91, a PEG ratio of 4.06 and a beta of 0.34. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 6.79.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its earnings results on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.03. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The firm had revenue of $5.11 billion during the quarter, compared to the consensus estimate of $5.03 billion. During the same quarter in the prior year, the company earned $0.91 EPS. The firm's revenue for the quarter was up 1.0% compared to the same quarter last year. Research analysts predict that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 17th will be paid a dividend of $0.52 per share. The ex-dividend date is Friday, October 17th. This represents a $2.08 annualized dividend and a yield of 2.7%. Colgate-Palmolive's dividend payout ratio is presently 58.43%.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on CL shares. UBS Group cut their price objective on Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating for the company in a report on Thursday, July 17th. Weiss Ratings reiterated a "hold (c)" rating on shares of Colgate-Palmolive in a report on Saturday, September 27th. Morgan Stanley cut their target price on Colgate-Palmolive from $104.00 to $96.00 and set an "overweight" rating on the stock in a report on Monday, August 4th. Barclays cut their target price on Colgate-Palmolive from $87.00 to $82.00 and set an "equal weight" rating on the stock in a report on Wednesday. Finally, Wells Fargo & Company cut their target price on Colgate-Palmolive from $83.00 to $80.00 and set an "underweight" rating on the stock in a report on Thursday, September 25th. Seven research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $94.83.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.